Bilirubin treatment significantly reduced leptin and slightly increased adiponectin levels 14 days post treatment (Fig. 3e,f), which supports the hypothesis that the effects of bilirubin on obesity and insulin resistance are, at least in part, mediated by leptin and adiponectin. The gene discussed is LEP; the disease is Obesity.